Collection of ophthalmic data to predict the effectiveness of Anti-VEGF treatment in diabetic patients by assessing the retinal thickness using artificial intelligence tools.
Not Applicable
- Conditions
- Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
- Registration Number
- CTRI/2021/05/033844
- Lead Sponsor
- Carl Zeiss India Bangalore Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Males or females 18 years of age or older
2. Patients who underwent OCT examination on CIRRUS HD OCT 5000 and/or Spectralis OCT
3. Type I or Type II diabetes with the case of DME in both eyes
4. Patients who underwent Anti-VEGF treatment
Exclusion Criteria
1. Subjects less than 18 years of age
2. Non-Diabetic subjects
3. Subjects with any comorbidities
4. Case of macular edema due to causes other than DME
5. Patients without follow up data
6. Patients with no pre-OCT data
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method